Bayer CropScience (506285) Q2 25/26 earnings summary

Executive summary

• Unaudited financial results for the quarter and half year ended September 30, 2025, were approved and reviewed by the Board and auditors.

• Interim dividend of ₹90 per equity share declared, payable on December 3, 2025, with a record date of November 14, 2025.

Financial highlights

• Revenue from operations for the quarter ended September 30, 2025, was ₹15,534 million; for the six months, ₹34,680 million.

• Profit before tax for the quarter was ₹2,003 million; for the six months, ₹5,355 million.

• Net profit for the quarter was ₹1,527 million; for the six months, ₹4,314 million.

• Earnings per share (EPS) for the six months ended September 30, 2025, was ₹95.99 (not annualised).

Outlook and guidance

• Business is seasonal in nature; quarterly figures may not represent full-year performance.